| Financial Year |
March 31 2023 |
| Monetary Funds |
572,080,998.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
66,806,622.54 |
| Accounts Receivable |
2,158,714,630.22 |
| Advances to Suppliers |
284,526,081.56 |
| Other Receivables |
151,539,432.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,241,837,553.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
114,924,986.47 |
| Total Current Assets |
4,812,238,157.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,339,790.76 |
| Investment Properties |
14,328,622.02 |
| Fixed Assetes |
2,941,674,829.35 |
| Under-construction Projects |
303,126,847.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
614,810,939.53 |
| R&D expenses |
28,625,355.12 |
| Goodwill |
678,973,114.12 |
| Long-Term Deferred and Prepaid Expenses |
39,963,203.84 |
| Deferred Income Tax Assets |
134,765,273.45 |
| Other Non-Current Assets |
92,141,416.89 |
| Sub-Total of Non-Current Assets |
5,688,022,578.95 |
| Total Assets |
10,500,260,736.37 |
| Short-Term Loans |
395,753,968.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,202,805,780.97 |
| Accounts Payable |
1,713,791,491.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
100,778,238.28 |
| Taxes Payable |
54,071,934.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,978,855.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
203,008,302.68 |
| Other Current Liabilities |
53,142,960.19 |
| Sub-Total of Current Liabilities |
4,204,369,354.58 |
| Long-term Loans |
1,372,259,980.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,415,639.93 |
| Deferred Income Tax Liabilities |
13,522,738.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,233,011,974.47 |
| Total Liabilities |
6,437,381,329.05 |
| Paid-In Capital(Or Share Stock) |
461,567,391.00 |
| Capital Surplus |
1,755,432,934.97 |
| Surplus Reserve |
234,117,609.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,401,172,685.72 |
| Minority Stockholder's Interest |
209,764,135.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,853,115,271.58 |
| Owner's Equity（Stockholder's Equity） |
4,062,879,407.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,500,260,736.37 |
